Inefficient killing of quiescent human epithelial cells by replicating adenoviruses: potential implications for their use as oncolytic agents
- 6 May 2005
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (8) , 691-698
- https://doi.org/10.1038/sj.cgt.7700840
Abstract
Cultured primary human cells have been widely used to assess the selectivity of oncolytic viruses as potential anticancer agents. As culture conditions can potentially have a significant impact on virus replication and ultimately cell killing, we evaluated the effects of dl309, a wild-type adenovirus, and dl01 / 07, a conditionally replicating adenovirus mutant, on quiescent and proliferating primary mammary epithelial cells. When primary cells were induced into quiescence, both viruses exhibited similar attenuated cell killing. However, cell killing by dl309 was superior to dl01 / 07 in proliferating primary cells. Analysis of viral effects at the level of entry, E2F activation, DNA replication, and late gene expression indicated that attenuation of dl309 in quiescent cells correlated with decreased expression of viral late genes such as hexon. In contrast, attenuation of dl01 / 07 in quiescent cells correlated with inefficient induction of E2F activity and inability to undergo efficient DNA replication. In proliferating cells, dl309 replicated efficiently, whereas dl01 / 07 still showed attenuated replication. In summary, our results indicate the intrinsic preference of wild-type adenoviruses for killing proliferating cells, which is an attractive feature for using adenoviruses as oncolytic agents. These results also highlight the need for the use of appropriate growth conditions for primary cells in vitro to distinguish subtle differences in cell killing among various oncolytic viruses.Keywords
This publication has 18 references indexed in Scilit:
- Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacyNature Biotechnology, 2001
- Nuclear Factor-κB (NF-κB) Regulates Proliferation and Branching in Mouse Mammary EpitheliumMolecular Biology of the Cell, 2001
- Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?Gene Therapy, 2001
- Evaluation of E1-Mutant Adenoviruses as Conditionally Replicating Agents for Cancer TherapyMolecular Therapy, 2000
- An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyNature Medicine, 2000
- Replicative adenoviruses for cancer therapyNature Biotechnology, 2000
- Adenovirus-mediated expression of green fluorescent proteinGene Therapy, 1997
- Analytical Anion-Exchange HPLC of Recombinant Type-5 Adenoviral ParticlesHuman Gene Therapy, 1997
- Purification of a Type 5 Recombinant Adenovirus Encoding Human p53 by Column ChromatographyHuman Gene Therapy, 1995
- An adenovirus type 5 early gene function regulates expression of other early viral genes.Proceedings of the National Academy of Sciences, 1979